Shanghai Haohai Biological Technology Co., Ltd. (HKG: 6826)
Hong Kong
· Delayed Price · Currency is HKD 29.00
-0.40 (-1.36%)
Nov 15, 2024, 4:08 PM HKT
Shanghai Haohai Biological Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,738 | 2,645 | 2,114 | 1,750 | 1,324 | 1,595 | Upgrade
|
| Other Revenue | 8.97 | 8.97 | 16.11 | - | - | - | Upgrade
|
| Revenue | 2,747 | 2,654 | 2,130 | 1,750 | 1,324 | 1,595 | Upgrade
|
| Revenue Growth (YoY) | 8.60% | 24.59% | 21.72% | 32.14% | -16.99% | 3.21% | Upgrade
|
| Cost of Revenue | 848.86 | 796.97 | 677.45 | 490.37 | 334 | 364 | Upgrade
|
| Gross Profit | 1,898 | 1,857 | 1,453 | 1,260 | 990.42 | 1,231 | Upgrade
|
| Selling, General & Admin | 1,206 | 1,225 | 1,073 | 898.43 | 772.49 | 813.11 | Upgrade
|
| Research & Development | 254.08 | 220.1 | 182.19 | 167.6 | 126.47 | 116.08 | Upgrade
|
| Other Operating Expenses | 38.91 | 9.17 | 7.89 | -3.18 | -1.37 | - | Upgrade
|
| Operating Expenses | 1,493 | 1,452 | 1,278 | 1,063 | 897.59 | 929.19 | Upgrade
|
| Operating Income | 404.78 | 404.94 | 174.67 | 196.9 | 92.83 | 302.31 | Upgrade
|
| Interest Expense | -11.71 | -7.29 | -7.6 | -4.96 | -4.91 | -4.54 | Upgrade
|
| Interest & Investment Income | 75.02 | 78.87 | 92.25 | 155.75 | 144.57 | 76.33 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 2.19 | -0.13 | 27.91 | Upgrade
|
| Currency Exchange Gain (Loss) | -5.61 | -5.61 | -2.68 | - | - | 2.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -10.16 | -2.71 | -2.78 | 32.77 | 24.66 | 48.53 | Upgrade
|
| EBT Excluding Unusual Items | 452.31 | 468.19 | 253.86 | 382.65 | 257.03 | 452.69 | Upgrade
|
| Impairment of Goodwill | - | - | -9.57 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.2 | 2.3 | -7.78 | - | - | -8.61 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.33 | 0.63 | 0.18 | - | - | 0.25 | Upgrade
|
| Asset Writedown | -8.27 | - | -36.5 | - | - | - | Upgrade
|
| Other Unusual Items | 61.19 | 37.14 | 35.49 | - | - | -9.98 | Upgrade
|
| Pretax Income | 505.35 | 508.26 | 235.73 | 382.65 | 257.03 | 434.35 | Upgrade
|
| Income Tax Expense | 104.07 | 95.99 | 45.39 | 35.37 | 30.69 | 57.97 | Upgrade
|
| Earnings From Continuing Operations | 401.28 | 412.27 | 190.33 | 347.28 | 226.34 | 376.38 | Upgrade
|
| Minority Interest in Earnings | 28.92 | 3.85 | -9.86 | 4.95 | 3.73 | -5.6 | Upgrade
|
| Net Income | 430.21 | 416.12 | 180.47 | 352.23 | 230.07 | 370.78 | Upgrade
|
| Net Income to Common | 430.21 | 416.12 | 180.47 | 352.23 | 230.07 | 370.78 | Upgrade
|
| Net Income Growth | 24.51% | 130.58% | -48.76% | 53.10% | -37.95% | -10.56% | Upgrade
|
| Shares Outstanding (Basic) | 329 | 334 | 340 | 345 | 347 | 320 | Upgrade
|
| Shares Outstanding (Diluted) | 329 | 334 | 340 | 345 | 347 | 320 | Upgrade
|
| Shares Change (YoY) | -1.78% | -1.72% | -1.47% | -0.62% | 8.72% | 1.85% | Upgrade
|
| EPS (Basic) | 1.31 | 1.24 | 0.53 | 1.02 | 0.66 | 1.16 | Upgrade
|
| EPS (Diluted) | 1.31 | 1.24 | 0.53 | 1.02 | 0.66 | 1.16 | Upgrade
|
| EPS Growth | 26.77% | 134.62% | -48.00% | 54.06% | -42.93% | -12.18% | Upgrade
|
| Free Cash Flow | 324.54 | 367.22 | -85.85 | 71.41 | 72.38 | 99.73 | Upgrade
|
| Free Cash Flow Per Share | 0.99 | 1.10 | -0.25 | 0.21 | 0.21 | 0.31 | Upgrade
|
| Dividend Per Share | 1.114 | 0.714 | 0.286 | 0.500 | 0.357 | 0.500 | Upgrade
|
| Dividend Growth | 290.02% | 150.02% | -42.86% | 40.02% | -28.58% | 40.02% | Upgrade
|
| Gross Margin | 69.10% | 69.97% | 68.20% | 71.98% | 74.78% | 77.19% | Upgrade
|
| Operating Margin | 14.74% | 15.26% | 8.20% | 11.25% | 7.01% | 18.95% | Upgrade
|
| Profit Margin | 15.66% | 15.68% | 8.47% | 20.13% | 17.37% | 23.24% | Upgrade
|
| Free Cash Flow Margin | 11.81% | 13.84% | -4.03% | 4.08% | 5.46% | 6.25% | Upgrade
|
| EBITDA | 566.64 | 573.69 | 352.62 | 332.03 | 206.21 | 399.19 | Upgrade
|
| EBITDA Margin | 20.63% | 21.62% | 16.55% | 18.97% | 15.57% | 25.02% | Upgrade
|
| D&A For EBITDA | 161.86 | 168.75 | 177.94 | 135.13 | 113.38 | 96.88 | Upgrade
|
| EBIT | 404.78 | 404.94 | 174.67 | 196.9 | 92.83 | 302.31 | Upgrade
|
| EBIT Margin | 14.73% | 15.26% | 8.20% | 11.25% | 7.01% | 18.95% | Upgrade
|
| Effective Tax Rate | 20.59% | 18.89% | 19.26% | 9.24% | 11.94% | 13.35% | Upgrade
|
| Revenue as Reported | 2,747 | 2,654 | 2,130 | - | - | - | Upgrade
|
| Advertising Expenses | - | 46.04 | 37.31 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.